InvestorNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) Submits Application for Expedited US Patent for Base Material Variant

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) announced that it has engineered a variation of its Beyond Tobacco(TM) base material which is used in its flagship TAAT(TM) product; the new formulation uses reconstituted plant-based materials and is designed for use in international markets where the current hemp-based formulation cannot be imported. In addition, the company has filed an expedited U.S. patent. According to the announcement, the new filing covers the expanded scope of base materials along with proprietary integrations with smartphones and wearable technologies designed to support smokers as they switch to TAAT. “Although hemp and various cannabinoids are fundamental to the TAAT and Beyond Tobacco vision with respect to the benefits they provide to adult tobacco smokers who are looking to leave nicotine behind, the use of hemp material inherently limits the global markets in which TAAT can be sold,” said TAAT founder Joe Deighan in the press release. “We are eager to enter regions such as Asia and the Middle East, where there is evident demand for a nicotine-free and tobacco-free alternative that is better than tobacco cigarettes. However, even in markets where legalization of hemp appears to be imminent at some point in the future, it can take a matter of years to actually happen. Instead of waiting around, we have spent the past several months developing a formulation of Beyond Tobacco using materials other than hemp that still provide a user experience nearly identical to that of smoking a tobacco cigarette. This can enable us to launch TAAT virtually anywhere in the world, as we continue to pursue market share in the USD $812 billion global tobacco industry.”

To view the full press release, visit https://ibn.fm/Ju8za

About TAAT Global Alternatives Inc.

TAAT Global Alternatives has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes that is offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $812 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.